TY  - GEN
AU  - Pitt,M
AU  - Crathorne,L
AU  - Moxham,T
AU  - Bond,M
AU  - Hyde,C
TI  - Everolimus for the second-line treatment of advanced and/or metastatic renal cell cancer: a critique of the submission from Novartis
SN  - 2046-4924
PY  - 2011///0308
KW  - Antineoplastic Agents
KW  - economics
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Cost-Benefit Analysis
KW  - England
KW  - Everolimus
KW  - Humans
KW  - Kidney Neoplasms
KW  - Randomized Controlled Trials as Topic
KW  - Sirolimus
KW  - analogs & derivatives
KW  - Wales
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
UR  - https://doi.org/10.3310/hta14suppl2/06
ER  -